NewsRoom Articles - Page 92 of 1390

FridayOct 25, 2024 11:15 am

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX): Tapping into Argentina’s Growing Copper Potential

Argentina is rapidly emerging as a key player in the global mining industry, positioning itself to become a significant producer of copper and other minerals critical to the world’s clean energy transition. The country’s ambition to rank among the top ten copper producers by 2030 reflects its immense potential, driven by vast untapped mineral reserves, recent policy reforms, and a growing pipeline of mining projects. Currently, Argentina holds an estimated 75.5 million metric tons of copper reserves, representing about 3% of the global total (https://nnw.fm/UEDnN). Although this is modest compared to copper giants like Chile and Peru, Argentina’s improving investment climate…

FridayOct 25, 2024 10:30 am

Report: Robots Are Revolutionizing Hospitality; Nightfood Holdings Inc.’s (NGTF) Game-Changing Automation Gameplan Revealed

The International Federation of Robotics released its latest report on the state of the robotics industry, showing a 30% surge in sales in 2023 to over 205,000 units The surge aligns perfectly with Nightfood Holdings recent acquisitions focused on the booming robotics revolution in hospitality Nightfood acquired Future Hospitality Ventures earlier this year and is acquiring the world-renowned Los Angeles Cooking School, training chefs and foodservice operators in the implementation of robotics, supplied through an innovative “Robotics-as-a-Service” business model As hospitality businesses grapple with labor shortages and rising operational costs, a single stark reality has set in: automate or die.…

FridayOct 25, 2024 9:45 am

Annovis Bio Inc. (NYSE: ANVS) Gets FDA Clearance for Buntanetap Pivotal Phase 3 Trials, Market Enthusiasm Highlighted in GuruFocus Article

Financial research platform GuruFocus underlines Annovis’ unique approach to tackling neurodegenerative conditions such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”). The FDA's decision to allow the company to go to Phase 3, points to the fact that lead drug candidate buntanetap may be an effective treatment for AD, one of the most critical diseases in an aging society. Buntanetap has been shown to significantly improve cognition in early AD patients, both by itself or on top of existing therapies. The Phase 3 program will consist of two trials: a 6-month study aimed at confirming buntanetap’s symptomatic benefits and an…

FridayOct 25, 2024 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Discusses Quantum Optimization, Presents Customer Success Stories at 2024 INFORMS Annual Meeting

D-Wave’s Vice President of Quantum Technology Evangelism, Murray Thom, was a featured speaker at the event’s Technology Showcase, detailing how D-Wave quantum technologies can tackle complex optimization problems. D-Wave’s Staff Technical Advisor Catherine Potts led an exhibitor workshop covering the fundamentals of quantum computing and demonstrated real-world cases. Participants were given the opportunity to explore D-Wave’s Leap(TM) real-time quantum cloud service, which features a portfolio of hybrid solvers able to deal with problems involving millions of variables and constraints. The 2024 INFORMS Annual Meeting was expected to attract 6,000 attendees, including members, students, prospective employers and employees, as well as…

ThursdayOct 24, 2024 10:30 am

Domestic Violence Case Highlights Importance of SuperCom Ltd. (NASDAQ: SPCB) GPS-enabled Electronic Monitoring Technology

Israel-based SuperCom is promoting public safety founded on the strength of its superior electronic monitoring (“EM”) technology platform SuperCom’s PureSecurity platform uses GPS to track the movements of individuals monitored by law enforcement on pretrial and probationary release from jail custody, including a 3-D elevation blueprint that is useful to apartment dwellers and office workers The importance of GPS-enabled tracking was highlighted in a recent New York State domestic violence case that reportedly led to a woman’s death when her accused attacker was freed from GPS monitoring The PureSecurity platform not only alerts supervising law enforcement about an EM-monitored individuals’…

ThursdayOct 24, 2024 9:45 am

Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Making ‘Significant Strides’ in Promising Black Sea Region

The Black Sea basin is estimated to contain significant amounts of natural gas. Being geographically closer to European markets and offering untapped potential, the Black Sea is ideally positioned to become a crucial supplier of natural gas to the area. With active projects in the region, particularly in the South Akçakoca Sub-Basin (“SASB”) off the coast of Türkiye, Trillion Energy is capitalizing on the area’s promise. In recent years, the Black Sea has emerged as a critical region for natural-gas exploration and development. As Europe seeks to diversify its energy sources, reduce dependency on Russian natural gas and transition to…

ThursdayOct 24, 2024 9:00 am

The MoneyShow Alternative Investing Virtual Expo

Market conditions no longer favor just one type or style of investing. That’s a key reason why MoneyShow is hosting the Alternative Investing Virtual Expo from Nov. 12, 2024, to Nov. 14, 2024. Traders and investors will gather to learn about alternative strategies and recommendations for the year ahead. Specifically, attendees can connect with distinguished industry investors to learn new ways to diversify and include different assets in their portfolios. Due to volatility in public markets, individuals are turning to private investment options to generate returns over longer time horizons, passive income, wealth protection, and increased stability. MoneyShow brings 43…

ThursdayOct 24, 2024 8:30 am

GolfLync’s Travel Feature: Your Ultimate Golfing Companion When Out of Town

For golfers, traveling often comes with the challenge of finding great courses and players in unfamiliar locations. Whether you’re heading out on vacation, a business trip, or simply visiting friends or family, GolfLync’s innovative travel feature ensures you can always tee off for a great time, no matter where you are. With this feature, GolfLync users can easily discover local golf courses and available tee times that match their preferences. Gone are the days of scrambling to find the right course or wondering who’s available to play or what stranger you might be paired up with. GolfLync’s travel feature, along…

WednesdayOct 23, 2024 10:30 am

Global Compliance Applications Corp. (CSE: APP) (OTCQB: FUAPF) Is ‘One to Watch’

Upstream Listing – GCAC began trading on Upstream in October 2024, expanding its global market access. Strategic Partnerships – Partnered with the Grunt Style Foundation in September 2024, enhancing veteran engagement. Streaming Services – Launched CGTV in September 2024, providing a legal advertising platform for cannabis companies. BOND Launch – In July 2024, GCAC introduced BOND on the Efixii Uplift platform, enabling secure, blockchain-driven consumer engagement. NFT Couponing – Launched Uplift NFT Coupons in March 2024, enabling personalized, verifiable promotions for cannabis brands while complying with legal advertising restrictions. Global Compliance Applications Corp. (CSE: APP) (OTCQB: FUAPF) is committed to…

WednesdayOct 23, 2024 9:45 am

Annovis Bio Inc. (NYSE: ANVS) Receives FDA Clearance to Initiate Pivotal Phase 3 Alzheimer’s Studies, Paving the Way for NDA Filings

Annovis Bio received FDA clearance to move forward with Phase 3 trials for buntanetap following an End-of-Phase 2 meeting on October 10, 2024. The pivotal trials will investigate buntanetap’s short-term symptomatic effects and potential long-term disease-modifying benefits in early-stage Alzheimer’s disease (“AD”) patients. Annovis Bio is targeting potential NDA submission within one year of the study’s initiation for symptomatic treatment, based on the results of a well-executed 6-month trial. The FDA raised no safety concerns regarding buntanetap and supported the use of its new crystal form in development. Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company focused on…

Financial news and publishing for public and private companies

Contact us: 512.354.7000